Research Article
TSH Variability of Patients Affected by Differentiated Thyroid Cancer Treated with Levothyroxine Liquid Solution or Tablet Form
Table 1
Baseline demographics and clinical characteristics of the patients at the first check-up.
| | Patients on liquid L-T4 (51 patients) | Patients on tablet L-T4 (51 patients) | value |
| Age (yrs) | 58.1 ± 11.6 | 56.9 ± 11.9 | 0.607 | Gender (M/F) | 9/42 | 13/38 | 0.327 | Mean tumour size (cm) | 1.6 ± 0.9 | 1.7 ± 1.0 | 0.596 | Weight (kg) | 59.5 ± 12.8 | 61.8 ± 9.2 | 0.303 | L-T4 dosage (mcg) | 128.7 ± 20.4 | 132.1 ± 20.4 | 0.407 | TSH (mIU/L) | 0.2 (0.1–0.4) | 0.2 (0.1–0.4) | 0.939 | FT4 (pg/mL) | 14.3 (10.9–17.4) | 14.2 (10.7–17.7) | 0.80 |
|
|
indicates median (min–max).
|